6-Year trends in lipids among adults in Shenzhen, China. (14th November 2019)

• Record Type: Journal Article
• Authors: Yuan, Xueli; Ni, Wenqing; Wang, Rui; Chi, Hongshan; Sun, Yuanying; Lv, Deliang; Liu, Peng; Xu, Jian
• Is Part Of: Journal of public health. Volume 42:Number 4(2020:Dec.)
• Page Start: e468
• Page End: e476
• Publication Date: 2019-11-14
• Subjects: dyslipidemia -- epidemiologic study -- risk factors -- serum lipids -- Shenzhen; Public health -- Periodicals; Public health -- Great Britain -- Periodicals; Medical policy -- Periodicals; Medical policy -- Great Britain -- Periodicals; 362.1
• DOI: 10.1093/pubmed/fdz113
• Languages: English
• ISSNs: 1741-3842

Abstract

Abstract: Background: There may be a beneficial effect on lipid levels in Shenzhen in recent years. In this study, we aimed to examine trends in serum lipids in population in Shenzhen between 2009 and 2015. Methods: We enrolled 2210 adults aged 18–70 years from two independent cross-sectional studies conducted in 2009 and 2015. Blood lipid profiles, such as total cholesterol (TC), triglyceride (TG), high-density lipoprotein cholesterol (HDL-C) and low-density lipoprotein cholesterol (LDL-C), were measured. Chi-square test, t -test and multivariate logistic regression analysis were applied for data analysis. Results: From 2009 to 2015, mean LDL-C declined from 3.05 ± 0.76 mmol/L in 2009 to 2.27 ± 0.75 mmol/L in 2015 ( P < 0.001). Similarly, a significant 7.09% decrease in the prevalence of high LDL-C was observed over the same period ( P < 0.001). There was an increasing trend in the prevalence of low HDL-C among adults in Shenzhen ( P < 0.001). A no-significant increase in prevalence of dyslipidemia was also observed over this 6-year interval ( P = 0.139). The prevalence of dyslipidemia was closely related with increasing age, male gender, current smoker, diabetes, obesity and overweight. Conclusion: This study shows a favourable downward trend in LDL-C concentration in Shenzhen. However, more intense strategies are needed to control dyslipidemia.